Literature DB >> 21664506

Clinical guidelines. Labor induction abortion in the second trimester.

Lynn Borgatta1, Nathalie Kapp.   

Abstract

Labor induction abortion is effective throughout the second trimester. Patterns of use and gestational age limits vary by locality. Earlier gestations (typically 12 to 20 weeks) have shorter abortion times than later gestational ages, but differences in complication rates within the second trimester according to gestational age have not been demonstrated. The combination of mifepristone and misoprostol is the most effective and fastest regimen. Typically, mifepristone 200 mg is followed by use of misoprostol 24-48 h later. Ninety-five percent of abortions are complete within 24 h of misoprostol administration. Compared with misoprostol alone, the combined regimen results in a clinically significant reduction of 40% to 50% in time to abortion and can be used at all gestational ages. However, mifepristone is not widely available. Accordingly, prostaglandin analogues without mifepristone (most commonly misoprostol or gemeprost) or high-dose oxytocin are used. Misoprostol is more widely used because it is inexpensive and stable at room temperature. Misoprostol alone is best used vaginally or sublingually, and doses of 400 mcg are generally superior to 200 mcg or less. Dosing every 3 h is superior to less frequent dosing, although intervals of up to 12 h are effective when using higher doses (600 or 800 mcg) of misoprostol. Abortion rates at 24 h are approximately 80%-85%. Although gemeprost has similar outcomes as compared to misoprostol, it has higher cost, requires refrigeration, and can only be used vaginally. High-dose oxytocin can be used in circumstances when prostaglandins are not available or are contraindicated. Osmotic dilators do not shorten induction times when inserted at the same time as misoprostol; however, their use prior to induction using misoprostol has not been studied. Preprocedure-induced fetal demise has not been studied systematically for possible effects on time to abortion. While isolated case reports and retrospective reviews document uterine rupture during second-trimester induction with misoprostol, the magnitude of the risk is not known. The relationship of individual uterotonic agents to uterine rupture is not clear. Based on existing evidence, the Society of Family Planning recommends that, when labor induction abortion is performed in the second trimester, combined use of mifepristone and misoprostol is the ideal regimen to effect abortion quickly and completely. The Society of Family Planning further recommends that alternative regimens, primarily misoprostol alone, should only be used when mifepristone is not available.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21664506     DOI: 10.1016/j.contraception.2011.02.005

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  14 in total

1.  Trends in use of medical abortion in the United States: reanalysis of surveillance data from the Centers for Disease Control and Prevention, 2001-2008.

Authors:  Karen Pazol; Andreea A Creanga; Suzanne B Zane
Journal:  Contraception       Date:  2012-07-06       Impact factor: 3.375

2.  Comparison of Effectiveness of Sublingual and Vaginal Misoprostol for Second-Trimester Abortion.

Authors:  Alka A Mukherjee
Journal:  J Obstet Gynaecol India       Date:  2018-12-04

3.  "It just seemed like a perfect storm": A multi-methods feasibility study on the use of Facebook, Google Ads, and Reddit to collect data on abortion-seeking experiences from people who considered but did not obtain abortion care in the United States.

Authors:  Heidi Moseson; Jane W Seymour; Carmela Zuniga; Alexandra Wollum; Anna Katz; Terri-Ann Thompson; Caitlin Gerdts
Journal:  PLoS One       Date:  2022-03-03       Impact factor: 3.240

4.  A Comparative Study of Misoprostol Only and Mifepristone Plus Misoprostol in Second Trimester Termination of Pregnancy.

Authors:  Prasanna Latha Akkenapally
Journal:  J Obstet Gynaecol India       Date:  2016-04-13

5.  Comparative Study of Misoprostol in First and Second Trimester Abortions by Oral, Sublingual, and Vaginal Routes.

Authors:  Deepika Nautiyal; Krishna Mukherjee; Inderjeet Perhar; Navnita Banerjee
Journal:  J Obstet Gynaecol India       Date:  2014-07-23

6.  Influence of Mifepristone in Induction Time for Terminations in the Second and Third Trimester.

Authors:  M Hoopmann; J Hirneth; J Pauluschke-Fröhlich; B Yazdi; H Abele; D Wallwiener; K O Kagan
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-03-28       Impact factor: 2.915

Review 7.  Oral contraception following abortion: A systematic review and meta-analysis.

Authors:  Yan Che; Xiaoting Liu; Bin Zhang; Linan Cheng
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

8.  Intra uterine extra-amniotic versus vaginal misoprostol for termination of second trimester miscarriage: A randomized controlled trial.

Authors:  Abo Bakr Abbas Mitwaly; Ahmed Mohamed Abbas; Mohamed Sayed Abdellah
Journal:  Int J Reprod Biomed (Yazd)       Date:  2016-10

9.  Efficacy of second-trimester termination procedure; medical, mechanic, or combine?

Authors:  Tuncay Yüce; Dilek Yüksel; Erkan Kalafat; Acar Koç
Journal:  Interv Med Appl Sci       Date:  2018-09

Review 10.  Public Health Impact of Legal Termination of Pregnancy in the US: 40 Years Later.

Authors:  John M Thorp
Journal:  Scientifica (Cairo)       Date:  2012-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.